# INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS

> **NCT03955848** · NA · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 80 (estimated)

## Conditions studied

- Adult Acute Myeloid Leukemia in Remission

## Interventions

- **BIOLOGICAL:** Alloreactive NK cell infusion

## Key facts

- **NCT ID:** NCT03955848
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-11
- **Primary completion:** 2019-05-16
- **Final completion:** 2022-05-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03955848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03955848, "INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03955848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*